Yearly Archives2018

Claudio De Simone, inventor of high-potency probiotic, sued pharmaceutical companies for making false advertising claims, ownership rights to the product formula and unpaid royalties November 26, 2018 09:30 AM Eastern Standard Time GREENBELT, Md. – A federal jury on Tuesday, Nov. 20, unanimously ruled in favor of a probiotic inventor who sued his former business partners after an international dispute concerning false advertising, ownership of a proprietary formulation and unpaid royalties. The inventor accused his former partners of attempting to make a copy of his invention and selling it to unsuspecting patients under the same brand name, even though the copy product had never been clinically tested. The three-week trial in the U.S. District Court for the District of Maryland ...

Clinical studies show a probiotic used to manage human GI disorders can help support bowel and gut health in dogs. ExeGi Pharma Launches a high potency veterinary probiotic for companion animals. ROCKVILLE, MD ExeGi Pharma LLC, a company focused on developing and commercializing live biotherapeutics and probiotic treatments, announced today the new Visbiome ® Vet. A new high potency veterinary probiotic for use in companion animals to help support normal inflammatory responses in the gastrointestinal tract (GI tract) and to help normalize gut health. The formulation in Visbiome Vet contains an eight-strain proprietary probiotic blend. This formulation has recently been studied in several canine GI disorders with two clinical trials published in the last 12 months. Moreover, Visbiome Vet is ...